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Development and feasibility testing of an
intervention to support active lifestyles in
youths with type 1 diabetes—the ActivPals
programme: a study protocol
Fiona Mitchell1*, Alison Kirk1, Kenneth Robertson2 and John J. Reilly1
Abstract
Background: The global incidence of type 1 diabetes is rising, and youths with type 1 diabetes continue to suffer
poorer health than peers without diabetes. Evidence suggests youths with type 1 diabetes have physical activity
(PA) levels well below the recommendations for health and have high levels of sedentary behaviour. An active
lifestyle is therefore recommended to improve health. There is limited research showing effective lifestyle behaviour
change in this population; therefore, an evidence gap exists between the need to promote physical activity in type
1 diabetes care and lack of understanding on how to do this. This protocol paper describes a feasibility and pilot
study of the ActivPals programme—an intervention to support active lifestyles in youths with type 1 diabetes.
Methods/design: Key intervention components have been identified from preliminary work (individual and family
focus, peer mentoring, technology integration and improved communication and understanding) and are being
developed into a pragmatic randomised controlled trial (RCT) supported by recruitment pathways. A steering group
of health care professionals and managers will refine the intervention to patient needs. A pilot trial is providing
data on intervention implementation, acceptability and feasibility. Twenty youths with type 1 diabetes are being
recruited and randomised into an intervention or control group. Physical activity is being measured objectively
using the Actigraph GT3X+ monitor at baseline and 1-month follow-up. Contextual factors associated with
intervention delivery are being explored.
Discussion: This study will contribute to the development of evidence-based, user-informed and pragmatic
interventions leading to healthier lifestyles in youths with type 1 diabetes.
Keywords: Type 1 diabetes, Physical activity, Intervention, Youths, ActivPals
Background
Type 1 diabetes is a chronic disease where the insulin-
producing pancreatic beta cells are destroyed resulting
in an inability of the body to regulate blood glucose. The
condition is managed by regular monitoring of blood
glucose, administering insulin and participating in a
healthy diet and regular physical activity [1]. Diabetes
has been a growing public health burden across the
world [2] with treatment for type 1 diabetes costing the
NHS in England roughly £1.802 billion a year [3]. The glo-
bal incidence of type 1 diabetes is rising with an estimated
70 % rise in the disease by 2020, in European adolescents
under age 15 [4]. Despite significant improvements in tech-
nology for blood glucose management, youths with type 1
diabetes continue to suffer from poorer health, relative to
peers without diabetes. For example, research suggests
there are higher mortality rates, more cardiovascular risk
factors, higher rates of depression, lower educational attain-
ment and poorer psychosocial health outcomes [5, 6].
Glycosylated haemoglobin (HbA1c) is a measure of
glycaemic control and is considered by both patients
and health care professionals to be at the core of type 1
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diabetes management [7]. HbA1c is an important marker
for risk of developing micro- or macrovascular complica-
tions of diabetes (such as retinopathy, nephropathy, cardio-
vascular disease and cerebrovascular disease) [8]. Diabetic
complications develop as a result of chronic hyperglycaemia
which causes damage to tissues and can develop as early as
2 years from diagnosis [9]. Improving HbA1c is therefore a
priority for youths with type 1 diabetes.
There is now a small body of evidence which suggests
regular physical activity (PA) can significantly reduce
HbA1c levels in individuals with type 1 diabetes [7, 10,
11]. This builds on the prolific evidence showing the
positive physical and psychological benefits of regular
PA in childhood and adolescence [12]. Regular physical
activity is therefore recommended in clinical guidelines
as one of the core elements of good type 1 diabetes
management [13]. Despite appreciation for the benefits
of physical activity, evidence suggests youths with type 1
diabetes are less physically active than peers without
diabetes [14–16]. For example, a recent study [16] found
that young people with type 1 diabetes aged 7–9 and
12–14 years spent on average 78 % (10.2 h/day) of the
waking day sedentary and 43 min/day participating in
moderate to vigorous PA. Sedentary behaviour is a
distinct class of behaviours (i.e. sitting, watching televi-
sion, playing video games) that is characterised by little
physical movement and low energy expenditure [17].
Only two of the 40 participants in the study achieved
minimum guidelines of PA participation of 60 min
moderate to vigorous intensity PA (MVPA) on each
accelerometer wear day, and 19/40 did not achieve
60 min of MVPA on any day. As PA levels are well
below the recommendations for health and sedentary
behaviour is high in youths with type 1 diabetes, there is
clearly a need for intervention studies to support this
population to lead an active lifestyle.
Whilst there have been a variety of published interven-
tion studies with youths with type 1 diabetes, there are limi-
tations with this work. For example, interventions have not
been based on behavioural change theories [10, 18], have
uncontrolled designs [19, 20], or consist of a very structured
supervised intervention design (e.g. using supervised struc-
tured exercise classes in the intervention) [20–24]. Whilst
short-term changes in PA might be evident with such su-
pervised settings, often, the PA behaviour reverts back to
pre-intervention levels when the supervised intervention is
removed [25]. No study has been conducted, to our know-
ledge, which is theoretically based, adopts a randomised
controlled design and has been tailored to young people
and families with type 1 diabetes to support long-term life-
style behaviour change. As such, there is a need for new,
higher quality (evidence informed and theoretically based)
interventions, which are developed using the UK Medical
Research Council (MRC) framework [26].
The MRC framework for evaluating complex interven-
tions will be used as the basis for this research [26]. The
framework strongly advises carrying out feasibility and
pilot work prior to running a full-scale trial; therefore, in
keeping with phases 1 and 2 of the MRC framework, this
study proposes to examine the feasibility of recruitment,
retention and acceptability of an RCT PA intervention
for youths with type 1 diabetes (see Fig. 1). This study
Phase 1:
Identify key behaviour 
change techniques & 
intervention components
Develop the ActivPals
PA intervention
Phase 2: 
Recruit and randomise 20 participants to 
ActivPals via 3 recruitment points 
Acceptability of the intervention 
Recruitment and retention.
Future work: 
blind full scale 
RCT
Fig. 1 MRC framework for designing and evaluating complex interventions
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aims to (1) develop a theoretically based tailored lifestyle
intervention (ActivPals programme) to support active
lifestyles for youths with type 1 diabetes and to (2) ex-
plore the feasibility of delivering this intervention. The
ActivPals programme is being developed from previous
work with youths with type 1 diabetes, which
highlighted the importance of peer and parental support
when leading an active lifestyle. This work will provide
critical information for the development of a definitive
trial, in addition to providing important information for
improving clinical care of type 1 diabetes in youths. The
intervention consists of two key phases:
Phase 1 specific objectives are to develop:
1. An intervention (ActivPals programme) to support
active lifestyles in youths with type 1 diabetes
2. Feasible recruitment pathways towards the
intervention
Importantly, the intervention and recruitment path-
ways will be evidence based whilst being pragmatic and
suitable for integration within current type 1 diabetes
NHS practice.
Phase 2 specific objectives are to recruit participants
and conduct a pilot and feasibility trial to determine:
1. The recruitment, initial retention and adherence
level that can be achieved for a 4-week intervention
programme in both the intervention and control
groups.
2. Preliminary evidence of effects of the intervention
on physical activity, sedentary behaviour and quality
of life. This will provide a preliminary indication of
whether the intervention can show change within
this group. Following this, an effect size will be
estimated for a ‘definitive’ randomised controlled
trial.
3. The acceptability of the intervention recruitment
pathways and intervention content, delivery,
duration and intensity to participants and health
professionals.
Methods
Study population
Participants will be included in phase 1 of the research if
they meet the following inclusion criteria:
1. Aged between 7 and 16 who have a medical
diagnosis of type 1 diabetes (a medical professional
will have previously tested glycated haemoglobin
(HbA1c) levels and provided a diagnosis)
2. Are registered in Greater Glasgow and Clyde
Children’s Diabetes Service
3. Are independently ambulatory
Parents and carers of possible participants will also be in-
vited to support the individual in participation. Individuals
will not be eligible to participate in the study if they have:
1. Been advised not to undertake physical activity by
their doctor
2. Severe learning disabilities and not able to
understand the study protocol
3. Severe challenging behaviour or other needs
requiring constant one to one support
Recruitment
Researchers have identified the need for a recruitment
strategy in RCTs [27, 28]. A strategy has been designed
to guide the recruitment process. The full strategy is
shown in Appendix. Participants will be recruited to
phase 2 via three recruitment points: (1) from paediatric
diabetes clinics (main recruitment site), (2) through sup-
port groups or clubs for young people with type 1 dia-
betes and (3) the diabetes nurses working at the hospital
will screen the medical records of paediatric patients
registered at the clinic for eligibility to participate in the
study. To ensure patient confidentiality, clinic staff will
screen the patient records and only retrieve information
on participant’s age, any exclusion criteria and next
appointment date. The staff and researcher will not dis-
cuss any information on patient files. The researchers
will assess the most effective recruitment routes which
will inform future work with this population. There are
three type 1 diabetes clinics per week at Yorkhill hospital
(the main recruitment site) and others across Greater
Glasgow and Clyde paediatric diabetes service. Greater
Glasgow and Clyde is the largest urban area in Scotland
and the fifth largest in the United Kingdom (UK) [29],
therefore offering a fairly representative sample of young
people living in urban areas in the UK. Participants who
attend a paediatric diabetes clinic and meet the inclusion
criteria will be informed of the study by the researcher
or by the paediatric consultant, diabetes doctors and
nurses. Those who are eligible and interested in partici-
pating in the study will be given an information pack
which will include more details about participation. Par-
ticipants can express interest in the study by signing and
returning a tear-off slip in the information pack and
posting it using the self-addressed envelope provided.
The researcher will then contact participants and ar-
range a visit to discuss the study. A strong collaboration
between the research group and the diabetes health care
team has already been established based on previous re-
search carried out with this population [10, 16].
Consent and randomisation
Participants who are interested and eligible to participate
will be randomised individually to the intervention or
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control group. As this is a small-scale feasibility and pilot
study, the researcher collecting the data will also deliver the
intervention. Therefore, it is not possible for the researcher
to be blind from the treatment group. Another member of
the research team (the PI) will randomise participants and
write the treatment allocation for each participant on a
piece of paper. This will be placed in a sealed envelope, only
to be opened by the researcher immediately before the
intervention/control group visit. Consent/assent will be
sought at two stages: firstly, for permission from the carer
to be contacted by the researcher to arrange appointments
and, secondly, written consent/assent to opt into participate
in each aspect of the study (physical activity intervention
component and interview component). This will be sought
at the study visits, once the researcher has discussed the
study in detail with participants. Written information sheets
will be given to participants (young people and parents/
carers). The researcher will go over the information sheet
with participants at the first visit to ensure that participants
understand the study protocol and what is being asked of
them.
Withdrawal of study participants
The participants will be given every opportunity to clar-
ify points they do not understand and, if necessary, ask
for more information. Participants will be given suffi-
cient time to consider the information sheets provided.
It will be emphasised that the participant may withdraw
their consent to participate at any time without loss of
benefits to which they otherwise would be entitled. Par-
ticipants will only be withdrawn from the study by the
researcher if the researcher perceives them to be at risk
or if there is a serious adverse event. If there is a serious
adverse event (e.g. injury from exercise, medical help
sought for diabetes), the details of this will be recorded
on a Serious Adverse Event form, provided by the local
NHS board and national good clinical practice will be
followed. The researchers will monitor any adverse
events during the study.
ActivPals intervention
The ActivPals intervention aims to:
 Support youths with type 1 diabetes to initiate and
maintain an active lifestyle, including increased
MVPA and reduced sedentary behaviour
 Be endorsed by NHS diabetes care staff highlighting
a clear integration of physical activity into diabetes
care and be of a duration and intensity realistic for
roll out in practice
The theoretical framework for the intervention will
draw on Social Cognitive Theory [30], which emphasises
the importance of self-efficacy and setting realistic goals.
Models of peer support [31], defined as ‘support from a
person who has experiential knowledge of a specific be-
haviour or stressor and similar characteristics as the tar-
get populations’, will also be the key to the intervention.
The ActivPals intervention will be tailored to the indi-
vidual’s baseline activity, activity preferences and local
opportunities. The inclusion of one or two parents or
carers or other support person throughout the full inter-
vention period will be strongly encouraged. The interven-
tion will be delivered by the researcher (first author) who
is collecting the data for the study. The intervention con-
sists of (1) an initial physical activity consultation [32] in-
corporating behaviour change techniques and (2) the use
of role modelling/peer mentors (athletes and roles models
with type 1 diabetes have endorsed the research and have
provided video messages to support young people with
type 1 diabetes to be more active). The third key compo-
nent of the intervention is the use of a wearable self-
monitoring device which syncs to a mobile app and web-
site. Continued support using social media/electronic
SMS text messages, telephone contact or email will also
be made by the researcher to encourage participants to
adhere to their physical activity plan. See Fig. 2 for a dia-
gram of the intervention components.
Phase 1 (4 months): aim—development of intervention
and recruitment pathways
The researchers have identified the key components of
the intervention that will be developed and piloted based
on prior work with this population. A steering group of
diabetes health care professionals and individuals at
management level will be established, using the James
Lind Alliance framework. The steering group will advise
on how these key components are implemented and will
assist with refining the intervention. The steering group
will help to guide the intervention to the needs of
patients, tailor intervention delivery within current clin-
ical practice and support dissemination to a broader
audience of patients and diabetes educators.
Physical activity consultation
The researchers have carried out previous work to identify
important components of an intervention [10, 16]. This
includes incorporating behaviour change techniques, edu-
cation and support for diabetes preparation and a combin-
ation of group and one to one support. A physical activity
consultation aligns well with these identified components
and has been successfully used with other diabetes groups
[32]. Guidelines on conducting this consultation have
been published for use in adults with diabetes [32]. The
consultation will involve an individual or group discussion
around physical activity and sedentary behaviour and aims
to increase motivation, provide education and develop an
individual tailored plan for supporting an active lifestyle.
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Strategies and techniques identified as important for sup-
porting behaviour change are incorporated to support ini-
tiation and maintenance of an active lifestyle. Examples of
strategies which may be included are investigating current
physical activity behaviour; discussing benefits, barriers
and costs of becoming more active; identifying suitable
activities; establishing and enhancing social support and
self-efficacy; setting personal goals and discussing relapse
prevention (Fig. 2).
Role modelling/peer mentors
Often, group structured education sessions are offered as
part of diabetes care. Group/peer support has been identi-
fied as an important component of an intervention to sup-
port active lifestyles in our previous research [10, 16].
During the development of the ActivPals intervention, we
will explore how the intervention could be integrated with
current diabetes group education sessions. In particular,
group sessions offer an opportunity to incorporate peer
support, involving sharing experiences, mentoring and role-
modelling. The suitability and feasibility of including peer
support within group educations will be explored during
intervention development. In addition, the inclusion of role
models/peer mentors will be examined. Peer mentors will
be athletes with type 1diabetes identified by the researchers.
Motivational videos will be provided as part of the interven-
tion, which will contain information about the benefits of
physical activity participation, particularly when living with
type 1 diabetes. Participants will be given the link to the
‘YouTube’ videos and encouraged to watch these regularly
in their own time, over the intervention period, to increase
PA.
Continued support through social media/emails or
telephone contact
We will explore the possible use of social media, emailing
or telephone support as a mechanism for continued
Support for 
parents- online 
forum. 
Participant self 
evaluation of 
current PA
Helping 
relationships /social 
support for PA 
(parents support 
participants to 
identify peer and
Reinforcement of 
importance of PA 
in diabetes care
Goal setting
(carers support 
participants)
Increasing self-
efficacy for PA
Wearable PA tracker/app
training session (parents and 
Increasing 
knowledge and 
reducing anxiety 
about hypos.
Parent self-
evaluation of 
own current 
PA?
AcPppfnnggggti
ogPlggannPPer
ering 
Core components of 
PAC for participants
and families
Additional 
components for 
parents 
Identifying and 
overcoming 
barriers to PA 
Peer role modelling 
(athlet  videos)
Action Planning 
Fig. 2 ActivPals PA intervention components
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support and to provide further information on aspects of
diabetes management.
Phase 2 (8 months): aim—feasibility trial
Once the ActivPals intervention has been developed, we
will conduct a feasibility study to explore intervention
feasibility and test practical aspects of study design.
Based on previous literature, an effect size will be esti-
mated for a subsequent definitive randomised controlled
trial.
Pilot procedures
Participants (child and parent/carer) will be visited a
minimum of four times during this pilot study. During
visit 1, basic demographic (gender, age), medical infor-
mation (body mass index, diabetes duration and current
therapy), PA and QoL questionnaires (see primary and
secondary outcome measures section) will be completed
and participants will be given an Actigraph activity
monitor and asked to wear this for the next 7 days. An
accelerometer wear diary will be given to participants to
record attachment and removal.
Visit 2 will occur approximately 8 days later. At this
point, activity monitors and wear diaries will be returned
and participants will then be randomised into the inter-
vention or control group. At this point, the researcher
will open the envelope to reveal the treatment group.
Those who have been allocated to the intervention arm
of the study will receive the PA consultation and inter-
vention materials. The intervention period will last
4 weeks, after which visit 3 will take place. During this
visit, both intervention and control participants will
once again be given an Actigraph activity monitor and
asked to wear this for the next 7 days. An accelerometer
wear diary will again be given to participants to record
attachment and removal. Visit 4 will occur approxi-
mately 8 days later during which time activity monitors
and wear diaries will be returned. Participants will be
asked to complete the PA and QoL questionnaires with
the researcher. Intervention participants will be invited
to participate in a short interview to explore views on
Visit 3, week 5 ±5 days
Post- intervention 
measurements + give 
accelerometer
4 weeks from baseline)
Visit 3, week 5 ±5 days
Control measurements + give 
accelerometer
4 weeks from baseline)
ActivPals intervention
PA consultation and 
4 week PA program 
Visit 2, 0 weeks
Baseline data 
collection + collect 
accelerometer
PA consultation 
and 4 week PA 
program 
Information packs 
provided
Randomisation
Visit 4, week 6 ±10 days  
Collect accelerometer. 
ActivPals intervention Waiting list control
Visit 1, 0-2 weeks 
prior to baseline
Information and 
consent meeting + 
give accelerometer 
Visit 4, week 6 ±10 days
Collect accelerometer and 
Qualitative interview
Visit 4, week 10 ±10 days
Qualitative interview
Fig. 3 Study flow chart
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the ActivPals intervention programme. At this point,
participants in the control group will be offered the
physical activity intervention, followed by an interview.
A wait list control design will be used as it would be un-
ethical to deny participants’ access to an intervention
which we believe is likely to be beneficial to health. See
Fig. 3 for study flow chart. More details on the pilot
study design are noted below following the PICOT
protocol (e.g. Population, Intervention, Comparison
group, Outcome measures (feasibility and patient
centred) and Timing).
Population
See the ‘Study population’ section.
Intervention
The ActivPals intervention programme will be developed
during phase 1.
Comparison group
The comparison group will receive standard diabetes care.
Control participants will be offered the intervention after
they have completed follow-up outcome measures.
Feasibility outcome measures
We will monitor the feasibility of the trial by tracking
recruitment, retention and adherence rates of partici-
pants and the most effective points of recruitment. In
addition, feedback about the delivery of the intervention,
intervention content and perceived impact will all be
explored through the qualitative interviews with partici-
pants and parents, carried out at the end of the study.
The researchers will also meet with the steering group at
the end of the study to feedback the results and discuss
intervention acceptability.
Patient-centred outcome measures
Objective measures of physical activity and sedentary be-
haviour will be collected using the Actigraph GT3X+
monitor. This monitor will allow objective recording of
daily time spent in sedentary, light and moderate to vig-
orous physical activity. These monitors are small (approx
size of a 2-pound coin) and lightweight (19 g). Partici-
pants will be asked to wear the accelerometers around
the waist during waking hours for 7 days, excluding
water-based activities. Accelerometer data will be down-
loaded to Actilife software (version 6.4.3). In line with
previous studies, a minimum wear time for a valid day
will be defined as 6 h/day, with 3 days of data required
for analysis inclusion [33, 34].
The primary outcome measure of daily time spent in
MVPA and sedentary behaviour will be determined using
cut-points calibrated and validated in paediatric studies:
sedentary (<100 cpm) [35] and MVPA (≥3200 cpm) [36].
In addition to the accelerometer data, information will be
gathered about the type, frequency and location (e.g.
school) of activities undertaken in the last 7 days. This in-
formation will be collected from participants with the help
of their parent/cares at baseline and follow-up (post-inter-
vention/control). This questionnaire will be developed
based on the findings of a previously conducted survey
study [37].
Generic and disease-specific questionnaires will be
used to measure quality of life in participants. The Ped-
sQoL 4.0 Generic Core Scale was used to measure gen-
eral quality of life [38]. This 23-item questionnaire
contains the following subscales: physical functioning,
emotional functioning, social functioning and school
functioning. A psychosocial health summary score will
be calculated from the average of the emotional, social
and school functioning subscales, a physical health
summary score (from the physical functioning subscale)
and a total overall score from the average of all sub-
scales. This scale has shown good reliability and validity
in this population [38, 39]. The PedsQoL 3.0 type 1
Diabetes Module is a 28-item questionnaire measuring
diabetes-specific QoL consists of five subscales: diabetes
symptoms, treatment barriers, treatment adherence,
worry and communication. Patients (self-report) and
their parents (proxy-report of the child’s QoL) will
complete questionnaires by rating items on how much
each was a problem in the previous month using a
5-point Likert scale (‘0’ = never a problem; ‘4’ = almost
always a problem). This questionnaire has been validated
and has shown to be reliable in children with type 1 dia-
betes [38, 40]. Changes in general QoL and diabetes
module scores will be analysed between intervention
and control groups to asses for any trends in interven-
tion effects.
We will also determine key process-related outcomes
including intervention recruitment, retention and com-
pliance. As mentioned, a qualitative interview will be
carried out post-intervention to determine contextual
factors associated with delivery of the intervention and
to explore patient and health professional experiences of
the ActivPals programme including acceptability of pro-
cedures, perceived benefits and difficulties. According to
the MRC framework [41], qualitative research can be
valuable for identifying what the important or ‘active in-
gredients’ of an intervention are and which elements are
not related to the ‘treatment effect’. Topics which will be
covered include perceptions of project, sport and PA
participation, views on intervention components, atti-
tudes towards PA, benefits and barriers towards PA and
sustainability of PA. A parent is encouraged to partici-
pate in the interview. With the participant’s permission,
the interviews will be recorded and transcribed. Other-
wise, notes taken during the interview will be written up
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in detail as soon as possible afterwards. Interviews will
be analysed by thematic analysis. Feasibility and accept-
ability measures will be reported including programme
implementation and fidelity to protocol.
The measures will give an indication of the effects of the
intervention on PA levels, sedentary behaviour and quality
of life. The acceptability of the measures and missing data
will be considered when designing the full-scale trial.
Timing
Outcome measures will be assessed at baseline (before
intervention) and 1 month after the initial physical activ-
ity consultation appointment.
This pilot RCT will be performed according to the
Research Governance Framework for Health and Com-
munity Care (second edition, 2006).
Statistics and data analysis
Descriptive statistics will be presented (mean and standard
deviation) with 95 % confidence intervals presented for
each group separately. Changes in physical activity and
QoL from baseline and follow-up will be assessed using
an ANOVA. As this is a feasibility and pilot study, the
study will be underpowered; therefore, quantitative out-
comes will be interpreted only as feasibility and pilot data.
Discussion
This paper describes the ActivPals study aims and design,
including information about the intervention, the out-
come measures and recruitment process. Whilst there is a
strong evidence base which suggests that regular PA can
have a range of physical and psychological benefits for
youths with type 1 diabetes, an evidence gap exists be-
tween the need to promote long-term lifestyle physical ac-
tivity in type 1 diabetes care and lack of understanding on
how to do this. A vital first step in developing this field is
development and piloting a theoretically based, pragmatic,
lifestyle intervention for youths with type 1 diabetes.
Limitations of the research
As this is a small-scale pilot and feasibility study, the re-
searcher (first author) will be recruiting participants, col-
lecting the data and also delivering the intervention. Whilst
we acknowledge that a double-blind pilot RCT would
strengthen the design of the study, there is limited time and
resource with this small-scale pilot study. Therefore, any
future funding applications to test the effectiveness of the
intervention would include costs for a health professional
and research assistant to avoid potential biases in the trial
design. Researcher bias will be reduced in the qualitative
element of the study as an MSc student, independent to
the study, will be conducting the interviews.
The time and funding limitations also restrict the
possibility of collecting post-intervention/control follow-
up data. Thus, it is not possible to assess long-term ef-
fects of the intervention in this small pilot study. These
limitations will be addressed in the next phase of work.
Perceived risk
As the aim of the intervention is to increase physical
activity levels, changes to lifestyle are encouraged. There
is unlikely to be any pain or discomfort associated with
increased physical activity. Participants will be advised to
carry out prescribed stretches before and after the
activity to minimise any muscle stiffness resulting from
exercise. These will be described in detail by the
researcher when delivering the intervention. Increased
exercise can cause hypoglycaemia in those with type 1
diabetes, if they are experiencing low blood sugar levels.
Participants will therefore be asked to monitor blood
sugar levels before and during exercising, and post exer-
cise, to minimise the risk of this occurring. Participants
will follow Greater Glasgow and Clyde children’s dia-
betes service exercise guidelines, which will be included
in the intervention information books for parents and
young people with type 1 diabetes (intervention re-
sources). The researcher will talk participants through
this information during the PA consultation. The inter-
vention will be individualised to each participant’s base-
line level of activity; therefore, the activity will begin at a
level that is comfortable and achievable. Activity inten-
sity, frequency and duration will increase progressively
over time. The intervention will be designed by experts
working in the physical activity and diabetes field who
have experience of advising on appropriate levels and
intensity of activity. At the end of the study, the re-
sources will be integrated with current routine care for
type 1diabetes (i.e. these will be offered to all patients
when they are visiting clinic). Participants will also be
given information about support networks and other
diabetes care team members they can speak to about in-
creasing physical activity.
Strengths of the research
A key strength of this study is that it aligns with the de-
velopment and feasibility stage of the MRC framework
for the development of complex health interventions.
The findings from this feasibility and pilot study will
generate output critical to the subsequent stage of the
MRC framework which is the development and running
of a definitive trial exploring the effectiveness of physical
activity and sedentary behaviour intervention within type
1 diabetes care (see Fig. 1). Specific output from phase 1
will be a new evidence-based, pragmatic and user-
informed intervention and suitable recruitment path-
ways to support active lifestyles for youths with type
1 diabetes. Specific output from phase 2 will be an
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important information on recruitment, initial retention
and the adherence level that can be achieved for a 4-
week intervention in both the intervention and control
groups. In addition, indicative effect of the intervention
on physical activity and sedentary behaviour will be im-
portant for the definitive trial. Acceptability of the inter-
vention, recruitment pathways and intervention content,
delivery, duration, intensity to participants and health
professionals will also be explored. The study will there-
fore lead to new knowledge of direct relevance to the
NHS for improving physical activity both in diabetes
care and in the care of youths with other chronic condi-
tions. Importantly, the qualitative interviews will provide
information about context of young people with type 1
diabetes lives and will also allow us to understand expe-
riences, attitudes, perceptions and behaviours following
completion of the ActivPals PA intervention. This ex-
ploratory work will be instrumental in designing and de-
veloping a full-scale trial to test the effectiveness of the
intervention.
The study is currently under way. All participants
were recruited from January to March 2016. Results
of the study will be submitted for publication from
January 2017.
Appendix
Recruitment strategy framework
Stage 1—pool
a) Identify target group within population or setting
Young people aged 7–16 with type 1 diabetes registered
at Greater Glasgow & Clyde Paediatric diabetes service.
b) Formative evaluation of recruitment approaches
A multipoint recruitment strategy will be used to
recruit from three main sources:
 GG & C paediatric diabetes clinics (main
recruitment site)
 New start (newly diagnosed) groups or support
groups or clubs for young people with type 1
diabetes
 Screen medical records of paediatric patients
registered at the clinic for eligibility to participate
in the study
Stage 2—invited
a) Offer invitation (January 2016–March 2016)
Information packs will be given out/sent to the paedi-
atric diabetes service and support groups by the research
associate (RA). These will contain a letter introducing
the study and information sheets for:
a) Children aged 7–11
b) Young people aged 12–16
c) A relative/parent
If participants would like to be contacted by the RA
with more information about the study, they are invited
to sign and return the tear-off slip in the self-addressed
envelope provided.
b) Monitor response uptake (January 2016–March
2016)
As monitoring the responses allows the researchers to
evaluate the effectiveness of the recruitment strategy
(Foster et al., 2011), the RA will monitor how many tear
slips are returned and where the participants were
recruited from. This will allow the team to asses to most
effective recruitment point.
Telephone reminders have been identified as an effect-
ive strategy for recruitment (Treweek et al., 2010); there-
fore, the researcher will phone participants who have
not returned their tear-off slip within a 2-week period.
This active method will serve as a reminder to partici-
pants and facilitate awareness of the study. Participants
can inform the researcher if they want more information
about the study or if they do not want to take part in
the study. If the information pack has been lost, the
researcher will send out another information pack.
Once all of the participant slips have either
returned forms or have confirmed to the research
secretary that they do not want to take part in the
study, the research team will review the number of
consenting participants and assess the success of the
recruitment strategy.
Stage 3—responded (January 2016–March 2016)
Participants who requested more information about
the study will be contacted by the RA to agree a date
and time for a home visit. This date/time will also be
agreed with a parent or nominated carer to ensure they
also receive information about the study.
a) Re-invitation to responders before intervention
begins
Foster et al. (2011) suggest that recruitment and reten-
tion to PA studies can be strengthened if participants
are invited to participate face to face. Thus, the RA will
visit each interested participant in their home (or alter-
native venue if preferred by participant) to provide more
information about the study. Consent forms will also be
given to the participants and parent/carer. Consent
forms can either be filled in whilst the RA is present or
these can be left with participants to allow them time to
consider their participation. If the participant is 11 years
or younger, a parent/carer must provide consent on the
young persons’ behalf, agreeing that they will support
the participant to take part in the programme. There will
also be an opportunity for participants, parent and
carers to ask questions pants about the study.
b) Facilitate attendance
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Evidence suggests that greater contact between trial ad-
visors and recruiting sites may increase recruitment (Lié-
nard 2006; Monaghan 2007). Therefore, the researcher
will carry out follow-up phone calls to interested partici-
pants. These will also act as reminders to participants,
parents/carers who have not returned consent forms. Par-
ticipants will also be encouraged to contact the research
team (or an identified colleague independent of the re-
search team) with any other queries.
c) Establish eligibility
 Seven to 16 years with type 1 diabetes registered
at Greater Glasgow and Clyde Paediatric diabetes
service.
 Independently ambulatory
 Are able to undertake physical activity (i.e. have
not been advised against doing more PA)
 Do not have a severe learning disability (and
therefore unable to understand the study
protocol)
 Do not have severe challenging behaviour or other
needs requiring constant one to one support
d) Screen participants
Participants will we be screened for eligibility based on
the inclusion/exclusion criteria.
e) Check all consent has been obtained
The RA will monitor and follow up consent forms.
The chief investigator will ensure informed consent is
obtained before any of the specific protocol procedures
are carried out.
f ) Baseline measurements carried out
g) Randomisation into intervention group/offer
starting date (January 2016)
Participants will be randomised into the ActivPals
intervention group or the waiting control group.
Stage 4—intervention begins (February 2016–April
2016)
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